含羞草社区

?
?
?
?
Home Tags Posts tagged with "Guokang Ruijin Pharmaceutical"

Tag: Guokang Ruijin Pharmaceutical

China Pharma monopoly fine
The Wrap

Record China pharma monopoly fine a deterrent, says expert

China issues record pharma fine, targeting firms and individual for monopoly violations

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Genting Group USD1.25bn Securities Offer

Linklaters steers Genting Group’s USD1.25bn securities offer

South Korea Global Standards Local Execution

Q&A: Korea’s global standards align with local execution

IHCF vice president SongYi Son discusses the merits and possible obstacles for doing business in South Korea

Faraz Alam Sagar

Faraz Alam Sagar leaves Cyril Amarchand to join CMS IndusLaw

Changes for chips

By Jaclyn Tsai, Jaime Cheng and Teresa Huang, Lee Tsai & Partners

Taiwan blends semiconductor innovation and regulation to stay ahead

Maternity Benefit Wage Definition Reform

New code brings ambiguity for maternity benefits

By Agrima Awasthi and Diksha Singh, Wadhwa Law Offices
Gilbert + Tobin Advises CDC Data Centres On USD2.75 Billion Fundraise

Gilbert + Tobin steers CDC’s USD2.75bn fundraise, debt reforms

Correspondents

Board Observer Regulationvideo

RBI scrutiny tightens over NBFC ‘board observers’

By Swathi Girimaji and Theertha Aiyappa, Bharucha & Partners
Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW
Follow 含羞草社区
Law firms Awards Events Legal jobs ? Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 含羞草社区. All rights reserved.

Follow us on LinkedIn